The global healthcare industry is witnessing a paradigm shift in ophthalmology, with age-related macular degeneration (AMD) emerging as a critical therapeutic area driving significant market transformation. As the world’s population ages and diagnostic capabilities improve, this specialized market segment is experiencing unprecedented growth and innovation. Market Valuation and Economic Impact The Age-Related Macular Degeneration Market Read.